Physician profile
Anna Mathew
NPI 1669402111
$486.63
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $367 · 2023: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $119.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $119.35 | 2023 | Erleada |
| Electronic Waveform Lab, INC. | $55.61 | 2019 | |
| Lilly USA, LLC | $49.73 | 2019 | |
| Pfizer INC. | $43.01 | 2019 | |
| Sentynl Therapeutics, INC. | $36.08 | 2019 | |
| Kaleo, INC. | $34.17 | 2019 | |
| Collegium Pharmaceutical, INC. | $33.81 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.45 | 2019 | |
| Neurocrine Biosciences, INC. | $22.60 | 2019 | |
| Daiichi Sankyo INC. | $20.83 | 2019 | |
| Avanir Pharmaceuticals, INC. | $17.35 | 2019 | |
| Promius Pharma LLC | $15.47 | 2019 | |
| Scilex Pharmaceuticals INC. | $12.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Mathew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.